Related Experiment Video
Updated: Feb 25, 2026

Rapid Molecular Detection and Differentiation of Influenza Viruses A and B
Published on: January 30, 2017
Suspected Pediatric Influenza Risk-Stratification Algorithm: A Clinical Decision Tool
Patrick D Evers1, Michelle Starr2, Michael J McNeil2
1From the Divisions of Cardiology.
Insights
This study developed the Suspected Pediatric Influenza Risk-Stratification Algorithm (SPIRA) to help clinicians identify children with influenza-like illness who truly need treatment, reducing unnecessary testing and medication.
Area of Science:
- Pediatric infectious diseases
- Clinical decision support systems
- Epidemiology
Background:
- Influenza poses a significant annual health burden on children.
- Current guidelines often lead to overtreatment or expensive viral testing for children with influenza-like illness (ILI).
- A need exists for better tools to differentiate children who require empiric treatment from those who need further testing.
Purpose of the Study:
- To develop and validate a risk-stratification algorithm for children presenting with ILI.
- To assist clinicians in determining the likelihood of influenza infection in pediatric patients.
- To optimize the use of empiric antiviral treatment and viral diagnostic testing.
Main Methods:
- Retrospective analysis of 818 children with ILI presenting to the emergency department.
- Review of medical records for symptoms, influenza risk factors, and viral assay results.
- Classification and regression tree analyses were conducted separately for children younger and older than 2 years.
Main Results:
- For children <2 years, influenza likelihood was associated with influenza-positive contact, lack of immunization, and high-incidence periods.
- For children ≥2 years, high-risk factors included lack of immunization, high-incidence periods, myalgia, and absence of diarrhea.
- Specific factors identified low risk for influenza in younger children (immunization, low-incidence season, absence of cough).
Conclusions:
- The Suspected Pediatric Influenza Risk-Stratification Algorithm (SPIRA) was developed based on these findings.
- SPIRA can guide clinicians in deciding between empiric treatment and viral testing for children with ILI.
- The algorithm aims to reduce unnecessary antiviral exposure and costly diagnostic procedures.
Background And Objectives:
Influenza causes significant annual burden among children. Current guidelines recommend empiric treatment for a broadly defined group of children at high risk for influenza complications, resulting in overtreatment or costly viral testing. This study creates an algorithm for clinicians to risk stratify children with influenza-like illness (ILI) according to likelihood of influenza infection.
Methods:
A retrospective analysis was performed on 818 children seen in the emergency department from November 2012 to April 2013 for ILI. We reviewed medical records for symptoms, influenza risk factors, and viral assay results. Classification and regression tree analyses were performed separately for children older and younger than 2 years.
Results:
In children younger than 2 years, populations likely to test positive were those with an influenza-positive contact, unimmunized children, and those presenting in high-incidence influenza periods. In this subgroup, immunized patients in low-incidence seasons and those with absence of cough are low risk for influenza infection. For children 2 years and older, high-risk populations were unimmunized children, those presenting in high-incidence influenza periods and those with myalgia or absence of diarrhea.
Conclusions:
These risk-stratification analyses were summarized into Suspected Pediatric Influenza Risk-Stratification Algorithm (SPIRA). For those in whom influenza infection is likely, clinicians may consider empiric treatment. Conversely, patients whom SPIRA identifies as unlikely to be infected with influenza are candidates for viral testing and targeted treatment. In assessing children with ILI, SPIRA aids clinicians in determining who to test versus treat empirically, saving children from costly viral testing or unnecessary antiviral exposure.
Related Concept Videos
Drug Dosing: Infants and Children
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Relative Risk
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...

